Hunniwell Lake Ventures invests in extensions of proven technologies within overlooked segments of the medical device space, aiming to make surgery safer, more accessible, and less invasive.
About Hunniwell Lake Ventures
Hunniwell Lake Ventures is a small US-based fund with an emerging healthcare-adjacent presence, investing primarily in early-stage technology companies with selective exposure to digital health and healthcare workflow software. Public information is limited beyond a website, LinkedIn, and Crunchbase, with no published fund size or detailed thesis. Plausible check sizes are $250K to $2M at seed and Series A, typically as a co-investor rather than a lead. Healthcare exposure appears partial and opportunistic, with the firm comfortable looking at AI-enabled software for providers, payers, and employers when paired with a strong team. AI focus is welcome but not exclusive. Founders best suited are seed and early Series A CEOs raising priced rounds with an institutional lead, who are looking to add a small high-trust check from a partner willing to be hands-off but available for warm introductions. Founders who do not fit include therapeutics, devices, and growth-stage companies needing larger checks and structured board governance. Geographic preference is US with no obvious regional bias. The entry path is warm introduction through a portfolio CEO or a co-investor, with LinkedIn outreach to a principal as a reasonable secondary option for founders with strong traction and a clear ask. Founders should not expect Hunniwell Lake to lead, and the firm is best deployed as supplemental capital alongside a healthcare-native anchor.
Founder reviews
Other portfolio companies
Companies in Hunniwell Lake Ventures's portfolio not currently in our directory.
- Picard Medical · 2021
- CoapTech · 2020
- WaveClear · 2020
Team
Pitch / review this investor
Have you raised from Hunniwell Lake Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).